ReviewComplement in the brain
Highlights
► Complement (C), a powerful tool of innate immunity, is important for defense of the brain. ► Most C proteins can be synthesized in the brain, mainly by glia but also by neurons. ► The C system is involved in both acute and chronic disorders of the brain. ► A delicate balance between C activators and regulators directs C to act as friend or foe. ► Recent findings suggests novel functions of C in brain development and synapse formation.
Introduction
Complement (C) is a major component of innate immunity, recognizing danger, as well as discriminating self from non-self (Ricklin et al., 2010). The C system is best known for its role in the recognition and killing of pathogenic microbes. Activation of the C system, which consists of over 30 soluble and cell-associated factors, can occur through three pathways, each triggered by different types of agents. All three pathways lead to the assembly of C3 convertases that, in turn, can cleave C3 resulting in formation of C3b and C3a activation products. The larger C3b fragment, a major effector molecule of the C system, acts as an opsonin and, in addition, together with other factors can assemble the C5 convertase, which enables further activation of the C cascade ultimately leading to generation of the chemotactic C5a fragment and the formation of the terminal complement complex C5b-9, also called membrane attack complex (Fig. 1). Thus, when the cascade is fully activated, C leads to assembly of the membrane attack complex (C5b-9; MAC) and lysis of invading microorganisms. However, if C5b-9 production is excessive or targeted to host cells, C5b-9 can induce host cell death. On the other hand, some C activation products also facilitate the generation of adaptive immune responses (Carroll, 2004, Erdei et al., 2009), while other components contribute to the control of autoimmunity during the clearance of apoptotic cells (Sjoberg et al., 2009, Fraser et al., 2009, van Kooten et al., 2008). Interestingly, sublytic amounts of C5b-9 on host cells may cause an influx of extracellular calcium that leads to activation and/or proliferation of the cells and resistance to induction of apoptosis (Cole and Morgan, 2003), further illustrating the diverse functions of this ancient pathway.
Binding of C1, a Ca2+-dependent complex of the recognition unit C1q and a tetramer of the proenzymes C1r and C1s, to an activator is the initial event in classical pathway (CP) activation of C. Activators can be immune complexes, certain microbes, apoptotic cells, and other specific protein motifs, such as amyloid in a fibrillar beta sheet structure found in the plaques in brain from Alzheimer's disease (AD) patients.
Mannose-binding lectin (MBL) and ficolins (Ficolin-1, -2 and -3) bind to mannan and other carbohydrate moieties or acetylated moieties on microorganisms or dying cells initiating C activation, through the lectin pathway (LP). MBL and ficolins share homology with C1q and, like C1q, are associated with proenzymes, MBL-associated serine proteases (MASPs).
The alternative pathway (AP) is initiated by spontaneous hydrolysis of the internal thioester within C3, resulting in C3b-like C3 (“tick-over”) or by recruitment of C3 by properdin bound to specific targets (Kemper and Hourcade, 2008). A range of microbial and also eukaryotic cell surfaces with a low sialic acid content allow AP C activation, whereas the inactivation of C3b by the C regulatory proteins (Creg) factor H (fH) and factor I (fI) is more efficient on surfaces rich in sialic acid (Austen and Fearon, 1979). C3b generated by the CP or MP activation pathways can enlist the alternative pathway components, thereby amplifying the amount of downstream complement cascade events (Fig. 1).
The brains of organisms with a well developed central nervous system (CNS) are shielded by the blood–brain-barrier (BBB) with tight junction formations at three principal barrier sites (i) the BBB formed by endothelial cells in the cerebral capillaries, (ii) the arachnoid barrier formed by the arachnoid multi-layered epithelium and (iii) the blood-CSF barrier formed by the CSF-secreting choroid plexus epithelium. The integrity properties are further defined by BBB-associated cells including pericytes and astrocytes. Together these brain barriers efficiently prevent infiltration of circulating immune cells, such as B- and T lymphocytes, and minimize influx of plasma proteins as well as neuroexcitatory and neurotoxic substances from the blood (reviewed in Abbott et al., 2010). The functions of immune surveillance and differentiation between “self” and “nonself” in non-CNS tissue, provided by neutrophils, dendritic cells, macrophages and natural killer cells in the periphery, are in the CNS attributed to resident glial cells including astrocytes, microglia, oligodendrocytes, and NG2 chondroitin sulphate (NG2) and platelet-derived growth factor-α receptor (PDGFα) positive oligodendrocyte precursor cells (NG2+PDGFα+ OPCs) (Butt et al., 2005 and reviewed in Dong and Benveniste, 2001, Griffiths et al., 2009). Much of our understanding of the occurrence and role of complement in the CNS derives from studies into the pathogenic mechanisms involved in various diseases affecting the brain. In a variety of CNS diseases, including bacterial meningitis, transmissible spongiform encephalopathies (TSE; prion disease), stroke and in more chronic conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), Huntington's (HD) and Parkinson's disease (PD), AD, as well as age-related macular degeneration (AMD), C contributes to the inflammatory process (Woodruff et al., 2008, Bonifati and Kishore, 2007). In this review we discuss the findings that have led to insight on the role of C in acute and chronic brain disorders and, importantly, its role in the normal homeostasis and brain functioning, as more recent studies (Stevens et al., 2007) indicate that C is also involved in brain development and synapse pruning.
Section snippets
Local synthesis of complement and complement regulators in the brain
The liver is the main source of C proteins, but although the BBB is not absolute and some macromolecules can by-pass the barriers by use of extracellular routes (Broadwell and Sofroniew, 1993) most C proteins are unlikely to penetrate the brain parenchyma unless the BBB integrity is disrupted. Therefore, local synthesis of C components by resident cells in the brain is crucial to appropriate functions of the local defense system. Local synthesis of C proteins in the brain was suggested after
The role of complement in normal CNS
Similar to other proteins that are part of the immune system, such as proinflammatory cytokines (e.g., TNFα, IL-6) and proteins of the adaptive immune system (e.g. major histocompatibility complex class I [MHCI] molecules and MHCI-binding immunoreceptors and their components (e.g., PIRB, Ly49, DAP12, CD3ζ) (for a review see Boulanger, 2009), C factors are now thought to also have nonimmune functions in the brain. Complement proteins were found to promote proliferation and regeneration in
Complement during acute brain injury
Acute brain injuries including infections, brain trauma, ischemic and hemorrhagic stroke and subsequent reperfusion injuries are to date associated with a limited repertoire of effective treatments and high morbidity. Neurodegeneration and death in these acute conditions can be via necrosis or via apoptosis. For example, apoptosis was recently shown to be dominant in the peri-infarct area after ischemic stroke in humans (Sairanen et al., 2006). Most likely neuronal death following acute
Complement during chronic conditions of brain injury
Substantial advances in understanding the effects of C in the brain comes from research in neurodegenerative diseases (ND) and subsequent studies with animal models for ND including C knock outs or genetically manipulated animals over expressing certain C factors bred to AD mouse models. Here we will focus on only a few diseases that demonstrate some of the mechanisms of disease acceleration and begin to provide insight on potential therapeutic targets. Recent reviews of the pathogenesis of age
Summary and future directions
In summary, various cell types in the CNS were shown to synthesize C factors, and the synthesis rates of many factors increase during development and within the injured brain. Data from human immunohistochemistry, animal models of diseases, and in vitro studies suggest that the role of C in AD is complex, with evidence for both detrimental and beneficial functions, presumably dependent on location, timing, and environmental signals. The potential disease associated polymorphisms of C factors
Acknowledgements
The work in the authors’ lab reported here was supported by NIH grants NS35144 and AG 00538 (AT), Stchting Dioraphte, Hersenstichting Nederland and Internationale Stichting Alzheimer Onderzoek (06-517) (RV) and Demensfonden and Alzheimerfonden (HN). The authors thank Dr. Maria I. Fonseca (University of California, Irvine) for Fig. 2.
References (181)
- et al.
Structure and function of the blood-brain barrier
Neurobiol. Dis.
(2010) - et al.
Localization and cell association of C1q in Alzheimer's disease brain
Exp. Neurol.
(1996) - et al.
Brain microglia constitutively express B-2 integrins
J. Neuroimmunol.
(1990) - et al.
Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices
FEBS Lett.
(1991) - et al.
C1, MBL-MASPs and C1-inhibitor: novel approaches for targeting complement-mediated inflammation
Trends Mol. Med.
(2008) - et al.
Characterization of C3a and C5a receptors in rat cerebellar granule neurons during maturation, Neuroprotective effect of C5a against apoptotic cell death
J. Biol. Chem.
(2004) - et al.
Role of complement anaphylatoxin receptors (C3aR C5aR) in the development of the rat cerebellum
Mol. Immunol.
(2008) - et al.
Complement proteins C1q and MBL are pattern recognition molecules that signal immediate and long-term protective immune functions
Mol. Immunol.
(2007) - et al.
Role of complement in neurodegeneration and neuroinflammation
Mol. Immunol.
(2007) Immune proteins in brain development and synaptic plasticity
Neuron
(2009)
Serum proteins bypass the blood-brain fluid barriers for extracellular entry to the central nervous system
Exp. Neurol.
Beta-amyloid peptides initiate the complement cascade without producing a comparable effect on the terminal pathway in vitro
Exp. Neurol.
Decreases in protease nexins in Alzheimer's disease brain
Neurobiol. Aging
The role of complement and activated microglia in the pathogenesis of Alzheimer's disease
Neurobiol. Aging
Expression and role of CR1 and CR2 on B and T lymphocytes under physiological and autoimmune conditions
Mol. Immunol.
Minocycline does not affect amyloid beta phagocytosis by human microglial cells
Neurosci. Lett.
Neuronal localization of C1q in preclinical Alzheimer's disease
Neurobiol. Dis.
Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease
Brain Res. Brain Res. Rev.
Expression of the complement classical pathway by human glioma in culture, A model for complement expression by nerve cells
J. Biol. Chem.
Complement activation on human neuroblastoma cell lines in vitro: route of activation and expression of functional complement regulatory proteins
J. Neuroimmunol.
Complement association with neurons and beta-amyloid deposition in the brains of aged individuals with Down Syndrome
Neurobiol. Dis.
Development of a novel therapeutic suppressor of brain proinflammatory cytokine up-regulation that attenuates synaptic dysfunction and behavioral deficits
Bioorg. Med. Chem. Lett.
Ultrastructural localization of complement membrane attack complex (MAC)-like immunoreactivity in brains of patients with Alzheimer's disease
Brain Res.
Properdin: New roles in pattern recognition and target clearance
Mol. Immunol.
The role of the anaphylatoxins in health and disease
Mol. Immunol.
Immune activation in brain aging and neurodegeneration: too much or too little?
Neuron
The immunogenesis of the multiple sclerosis plaque
Brain Res.
Activation of the classical complement pathway in brain tissue of Alzheimer patients
Neurosci. Lett.
Distribution of clusterin in Alzheimer brain tissue
Brain Res.
The role of complement anaphylatoxin C5a in neurodegeneration: implications in Alzheimer's disease
J. Neuroimmunol.
The axonally secreted serine proteinase inhibitor, neuroserpin, inhibits plasminogen activators and plasmin but not thrombin
J. Biol. Chem.
The complement cascade: Yin-Yang in neuroinflammation–neuro-protection and -degeneration
J. Neurochem.
A molecular basis of activation of the alternative pathway of human complement
Adv. Exp. Med. Biol.
Immunoglobulins and complement in postmortem multiple sclerosis tissue
Ann. Neurol.
Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion
Ann. Neurol.
Complement activation in the human brain after traumatic head injury
J. Neurotrauma
Complement protein C1q-mediated neuroprotection is correlated with regulation of neuronal gene and microRNA expression
J. Neurosci.
Activation of the contact system in cerebrospinal fluid of patients with Alzheimer disease
Alzheimer Dis. Assoc. Disord.
Peripheral treatment with enoxaparin, a low molecular weight heparin, reduces plaques and beta-amyloid accumulation in a mouse model of Alzheimer's disease
J. Neurosci.
Subpial demyelination in the cerebral cortex of multiple sclerosis patients
J. Neuropathol. Exp. Neurol.
Signaling through C5aR is not involved in basal neurogenesis
J. Neurosci. Res.
The cell-adhesion G protein-coupled receptor BAI3 is a high-affinity receptor for C1q-like proteins
Proc. Natl. Acad. Sci. U. S. A.
Complement-dependent proinflammatory properties of the Alzheimer's disease beta-peptide
J. Exp. Med.
Homogeneity of active demyelinating lesions in established multiple sclerosis
Ann. Neurol.
The pathology of multiple sclerosis is location-dependent: no significant complement activation is detected in purely cortical lesions
J. Neuropathol. Exp. Neurol.
Synantocytes: the fifth element
J. Anat.
Expression of innate immune complement regulators on brain epithelial cells during human bacterial meningitis
J. Neuroinflamm.
Analysis of epitope expression and the functional repertoire of recombinant complement receptor 2 (CR2/CD21) in mouse and human cells
J. Immunol.
The complement system in regulation of adaptive immunity
Nat. Immunol.
IFN-gamma promotes complement expression and attenuates amyloid plaque deposition in amyloid beta precursor protein transgenic mice
J. Immunol.
Cited by (310)
Pharmacologic Manipulation of Complement Receptor 3 Prevents Dendritic Spine Loss and Cognitive Impairment After Acute Cranial Radiation
2024, International Journal of Radiation Oncology Biology PhysicsComplement proteins are elevated in blood serum but not CSF in clinical high-risk and antipsychotic-naïve first-episode psychosis
2023, Brain, Behavior, and ImmunityChromosomal and gonadal factors regulate microglial sex effects in the aging brain
2023, Brain Research BulletinPerspectives on complement and phagocytic cell responses to nanoparticles: From fundamentals to adverse reactions
2023, Journal of Controlled Release